<code id='6AB4FD744C'></code><style id='6AB4FD744C'></style>

<acronym id='6AB4FD744C'></acronym>

<center id='6AB4FD744C'><center id='6AB4FD744C'><tfoot id='6AB4FD744C'></tfoot></center><abbr id='6AB4FD744C'><dir id='6AB4FD744C'><tfoot id='6AB4FD744C'></tfoot><noframes id='6AB4FD744C'>

<optgroup id='6AB4FD744C'><strike id='6AB4FD744C'><sup id='6AB4FD744C'></sup></strike><code id='6AB4FD744C'></code></optgroup>

<b id='6AB4FD744C'><label id='6AB4FD744C'><select id='6AB4FD744C'><dt id='6AB4FD744C'><span id='6AB4FD744C'></span></dt></select></label></b><u id='6AB4FD744C'></u>

~~<i id='6AB4FD744C'><strike id='6AB4FD744C'><tt id='6AB4FD744C'><pre id='6AB4FD744C'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

hotspot

author：leisure time 2025-10-02 04:26:41 Page View：866

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

advertisement

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At flashy new research hub, AstraZeneca lays out ambitious growth goals
Next article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

explore

The high cost of giving birth even with insurance

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

Study finds gene variants tied to breast cancer risk in Black women

Study finds gene variants tied to breast cancer risk in Black women

AdobeHundredsofgeneticvariantscannudgesomeone’sriskofbreastcancerupordownortowardsaparticularsubtype

The cancer drug shortage isn’t new — and neither are the solutions

The cancer drug shortage isn’t new — and neither are the solutions

PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

For longer

MarianF.MoratinosforSTATEnticedbytheimmensemarketopenedbyGLP-1weightlossdrugsWegovyandZepbound,ahand

read more